Oxford Nanopore Technologies (LON:ONT) Trading Up 10% – Should You Buy?

Posted by Amber O'Connor on Dec 1st, 2024

Shares of Oxford Nanopore Technologies plc (LON:ONT – Get Free Report) rose 10% during trading on Friday . The company traded as high as GBX 161.64 ($2.06) and last traded at GBX 161.64 ($2.06). Approximately 101,398,086 shares were traded during trading, an increase of 4,224% from the average daily volume of 2,345,044 shares. The stock had previously closed at GBX 146.90 ($1.87).

Analysts Set New Price Targets

A number of research analysts have issued reports on ONT shares. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 282 ($3.59) target price on shares of Oxford Nanopore Technologies in a report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 190 ($2.42) price objective on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Five analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of GBX 235.50 ($3.00).

Read Our Latest Analysis on ONT

Oxford Nanopore Technologies Stock Up 8.3 %

The company has a debt-to-equity ratio of 8.07, a current ratio of 4.45 and a quick ratio of 6.01. The firm’s 50-day moving average price is GBX 144.02 and its 200 day moving average price is GBX 125.34. The firm has a market capitalization of £1.50 billion, a price-to-earnings ratio of -795.50 and a beta of 0.80.

Insider Activity

In related news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the business’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of GBX 142 ($1.81), for a total transaction of £2,830,870.82 ($3,605,745.54). In the last three months, insiders acquired 306 shares of company stock valued at $44,850. Company insiders own 32.62% of the company’s stock.

About Oxford Nanopore Technologies

(Get Free Report)

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.